GLP-2 15mg

Tirzepatide is a dual incretin peptide researched for metabolic support, body-weight reduction, and blood sugar regulation. It is commonly grouped with advanced weight-management compounds because it acts across multiple appetite and glucose-control pathways. In research settings, it is associated with reduced food intake, improved satiety, delayed gastric emptying, and broader metabolic support compared with single-pathway incretin compounds.